学者信息

罗文新 (WenXin Luo)

公共卫生学院

ResearcherID:G-4640-2010

合作者

已发表成果:

WOK 论文 52 篇;中文核心 34 篇;其它论文 11 篇;专利发明 16 个;

  • A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression <i>in vivo</i>

    FRONTIERS IN PHARMACOLOGY,,2023-12-27.
    You, Min; Chen, Fentian; Yu, Chao; Chen, Yuanzhi; Wang, Yue; Liu, Xue; Guo, Xueran; Zhou, Bing; Wan...
    WOS:001139364000001   10.3389/fphar.2023.1213726
    收录情况:SCIE
  • Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

    NEW ENGLAND JOURNAL OF MEDICINE,0028-4793,2023-08-31.
    Li, Tingdong; Li, Fugui; Guo, Xiaoyi; Hong, Congming; Yu, Xia; Wu, Biaohua; Lian, Shifeng; Song, Li...
    WOS:001086344300008   10.1056/NEJMoa2301496
    收录情况:SCIE
  • Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

    PROTEIN & CELL,1674-800X,2023-07-20.
    Sun, Hui; Deng, Tingting; Zhang, Yali; Lin, Yanling; Jiang, Yanan; Jiang, Yichao; Huang, Yang; Song...
    WOS:001043062500001   10.1093/procel/pwad040
    收录情况:SCIE
  • Abnormally primed CD8 T cells: The Achilles' heel of CHB

    FRONTIERS IN IMMUNOLOGY,1664-3224,2023-03-01.
    Chen, Xiaoqing; Liu, Xue; Jiang, Yichao; Xia, Ningshao; Liu, Chao; Luo, Wenxin
    WOS:000948786000001   10.3389/fimmu.2023.1106700
    收录情况:SCIE
  • T细胞重定向双特异性抗体在肿瘤治疗中的挑战与应对策略

    中国生物工程杂志,1671-8135,2023-06-25.
    秦晓静;刘雪;罗文新
    CSCD核心库
  • 抗病毒抗体Fc效应功能研究进展

    病毒学报,1000-8721,2023-05-09.
    许涛;蒋艺超;陈小青;罗文新
    CSCD核心库